Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 15, 2013, Pages 2059-2064

  De Luis, D A ^a   Aller, R ^a   Izaola, O ^a   Gonzalez Sagrado, M ^a   Conde, R ^a   De La Fuente, B ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Adipocytokines; Alanine aminotransferase; Diabetes mellitus; Insulin resistance; Non alcoholic fatty liver disease; Obesity

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; INSULIN; TRIACYLGLYCEROL; CHOLESTEROL; GLUCOSE BLOOD LEVEL;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; FAT MASS; FEMALE; HEMOSTASIS; HUMAN; HYPERTRANSAMINASEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL ACTIVITY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGED; ANALYSIS; BLOOD; BODY FAT DISTRIBUTION; BODY SIZE; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK; SPAIN;

ADIPOKINES; ADULT; AGED; ALANINE TRANSAMINASE; BLOOD GLUCOSE; BODY FAT DISTRIBUTION; BODY MASS INDEX; BODY SIZE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ODDS RATIO; SPAIN; TRIGLYCERIDES;

EID: 84884272352     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. LUDWIG J, VIGGIANO TR, MCGILL DB, OH BJ. Non-alcoholic steatohepatitis: Mayo Clinic experiencies with a hitherto unnamed disease. Mayo Clinic Proc 1980; 55: 434-438. (Pubitemid 10057164)
2. KRAL JG, SCHAFFNER F, PIERSON RN, WANG J. Body fat topography as an independent predictor of fatty liver. Metabolism 1993; 42: 548-551. (Pubitemid 23141622)
3. CHITTURI S, ABEYGUNASEKERA S, FARELL GC, HOLMESWALKER J, HUI M, FUNG C, KARIM R, LIN R, SAMARASINGHE D, LIDDLE C, WELTMAN M, GEORGE J. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 35: 373-379. (Pubitemid 34106377)
4. MARCEAU P, BIRON S, HOULD FS, MARCEAU S, SIMARD S, THUNG SN, KRAL JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513-1517. (Pubitemid 30644245)
5. KUMADA M, KIHARA S, SUMITSUJI S, KAWAMOTO T, MATSUMOTO S, OUCHI N, ARITA Y, OKAMOTO Y, SHIMOMURA I, HIRAOKA H, NAKAMURA T, FUNAHASHI T, MATSUZAWA Y; OSAKA CAD STUDY GROUP. Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85-89. (Pubitemid 36091630)
6. SHIMOMURA I, HAMMER RE, IKEMOTO S, BROWN MS, GOLDSTEIN JL. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999; 401: 73-76.
7. DE LUIS DA, GONZALEZ SAGRADO M, CONDE R, ALLER R, IZAOLA O, DE LA FUENTE B, CASTRILLÓN JL, ROMERO E. Relation of resistin levels with cardiovasular risk factors and insulin resistance in non-diabetes obese patients. Diabetes Res Clin Pract 2010; 89: 110-114.
8. MATSUZAWA Y. Adipocytokines: Emerging therapeutic targets. Curr Atheroscler Rep 2005; 7: 58-62. (Pubitemid 40394231)
9. VOSAROVA B, STEFAN N, LINDSAY RS, SAREMI A, PRATLEY RE, BOGARDUS C. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51: 1889-1895. (Pubitemid 34564303)
10. MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF, TURNER RC. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. (Pubitemid 15018832)
11. PICHARD C, SLOSMAN D, HIRSCHEL B, KYLE U. Bioimpedance analysis in patients: an improved method for nutritional follow up. Clin Res 1993; 41: 53a.
12. MATAIX J, MAÑAS M. Tablas de composición de alimentos españoles. Ed: University of Granada, 2003.
13. MARCHESINI G, BRIZI M, MORSELLI-LABATE A, BIANCHI G, BUGIANESI E, MCCULLOUGH AJ, FORLANI G, MELCHIONDA N. Association of non-alcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-455. (Pubitemid 29528333)
14. SANYAL AJ, CAMPBELL SARGENT C, MIRSHASHI F, RIZZO WB, CONTOS MJ, STERLING RK, LUKETIC VA. Non-alcoholic steatohepatitis: association of insulin resistance and mitocohondrial abnormalities. Gastroenterology 2001; 120: 1183-1192. (Pubitemid 32246672)
15. RASHID M, ROBERTS EA. Non-alcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000; 30: 48-53.
16. DE LUIS DA, ALLER R, IZAOLA O, GONZALEZ SAGRADO M, CONDE R, BELLIDO D. Influence of insulin resistance and adipocytokines on elevated serum alanine aminotransferase in obese patients. Arch Med Res 2008; 39: 10-114.
17. ALLER R, DE LUIS DA, FERNANDEZ L, CALLE F, VELAYOS B, OLCOZ JL, IZAOLA O, GONZALEZ SAGRADO M, CONDE R, GONZALEZ JM. Infleuce of insulin resistance and adipokines in the grade of steatosis of non-alcoholic fatty liver disease. Dig Dis Sci 2008; 53; 1088-1092. (Pubitemid 351379844)
18. XU A, WANG Y, KESHAW H, XU A, WANG Y, KESHAW H. The fat derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver diseases in mice. J Clin Invest 2003; 112: 91-100. (Pubitemid 38056380)
19. LEE DH, HA HM, KIM JH, CHRISTIANI DC, GROSS MD, STEFFES M, BLOMHOFF R. Gamma glutamyltransferase and diabetes-a year follow up study. Diabetologia 2003; 46: 359-364.
20. PAGANO C, SOARDOO G, ESPOSITO W, FALLO F, BASAN L, DONNINI D, FEDERSPIL G. Plasma adiponectin is decreased in non-alcoholic fatty liver disease. Eur J Endocrinol 2005; 152: 113-118. (Pubitemid 40185459)
21. KAZUMI T, KAWAGUCHI A, HIRANO T, YOSHINO G. Serum alanine aminotransferase is associated with serum adiponectin, C reactive protein and apolipoprotein B in young Healthy Men. Horm Res Metab 2006; 38: 119-124.